<?xml version="1.0" encoding="UTF-8"?>
<ref id="B81-vaccines-08-00273">
 <label>81.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hu</surname>
    <given-names>W.-G.</given-names>
   </name>
   <name>
    <surname>Steigerwald</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kalla</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Volkmann</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Noll</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Nagata</surname>
    <given-names>L.P.</given-names>
   </name>
  </person-group>
  <article-title>Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses</article-title>
  <source>Vaccine</source>
  <year>2018</year>
  <volume>36</volume>
  <fpage>5194</fpage>
  <lpage>5203</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.06.064</pub-id>
  <pub-id pub-id-type="pmid">30037666</pub-id>
 </element-citation>
</ref>
